Recent News

• 09.12.2025 - 4DMT Announces New Employment Inducement Grants
• 09.09.2025 - Morgan Stanley Annual Global Healthcare Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Cantor Global Healthcare Conference 2025
• 09.02.2025 - 4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
• 08.25.2025 - 4DMT to Participate in Upcoming Investor Conferences
• 08.15.2025 - 4DMT Announces New Employment Inducement Grants
• 08.13.2025 - H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
• 08.11.2025 - 4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
• 08.06.2025 - 4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Recent Filings

• 08.11.2025 - 8-K Current report
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.02.2025 - 8-K Current report
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities